Von der Leyen’s Family Ties to Brussels Power

Ursula von der Leyen: Origins and Surrounding Interests

Her official profile lists a medical doctorate. Her birth certificate shows another surname: Albrecht. Ursula von der Leyen reached the presidency of the European Commission without direct elections, sparking most of the suspicions she faces. Her biography, family, and business connections, especially in healthcare, form a knot that public scrutiny has long tried to untangle. It is essential to separate documented facts from mere accusations.

From Albrecht to Brussels: A Career Without Ballots

The surname she uses is not her birth name. Born Ursula Albrecht, her father was reportedly one of the early officials of the nascent European Community structure. This detail explains why her institutional rise seems preordained: "from an old aristocratic family," say those who cite it.

She trained as a physician and has an extensive personal history: seven children. This seemingly domestic detail has become ammunition in analyses regarding carbon footprint and climate emergency, because the same leader demanding energy austerity has a large family. The criticism is not exclusive to one side. She remains in office, though citizens never voted for her directly.

The Husband, Orgenesis, and Gene Therapy Business

Heiko von der Leyen, the President's husband, is Chief Medical Officer at Orgenesis, a US biotech firm specializing in gene therapies, the same basis for Pfizer and Moderna vaccines. He joined its scientific board in 2019 and took his current role the year before this discussion arose, according to circulating accounts. Orgenesis works on the BioShield program, a declared super-vaccine project currently being tested in mice.

Before that, Heiko von der Leyen and Orgenesis Vice President Vincent Wandamm worked eleven years for GlaxoSmithKline. Wandamm had been Pfizer’s quality director for eight years. Many Orgenesis employees previously worked at the US multinational, and major shareholders of both companies overlap, based on New York Stock Exchange data. In August 2019, GSK and Pfizer announced combining several businesses into the joint venture GSK Consumer Healthcare.

How Much Money in the EU-Pfizer Contract?

Here the figures become uncomfortable. Contracts between Pfizer and the European Commission have not been made public, and messages and calls between both parties were allegedly deliberately deleted. Based on this opacity, a circulating estimate suggests that at $20 per dose, Pfizer billed the EU around $36 billion. With the standard 2% commission in Brussels for such volumes, someone would have earned $760 million. None of this is confirmed: these are estimates, not documents.

Suspicion is always formulated conditionally, which is the key point. There is no public confirmation that commissions were paid, their amount, or who received them.

McKinsey, Son David, and the Bundeswehr Contract

Another front involves her son. David von der Leyen works at consultancy McKinsey and shared in its profits, according to reported information. McKinsey allegedly received millions of euros advising the Bundeswehr, the German army, while his mother was Defense Minister. The same firm designed pandemic communication campaigns and vaccine distribution logistics. It is the kind of coincidence that proves nothing but fuels everything.

Does She Want to Repeal the Nuremberg Code?

Claims circulate that the President intends to repeal the Nuremberg Code to impose mandatory vaccination on the Union’s 445 million inhabitants. There is no public record of such legislative initiative. Mandatory vaccination remains a national decision, not a Brussels one.

What is indeed on the table is a fundamental problem: the perception that EU health decisions and the private interests of those making them share too many addresses.

If contracts are unpublished and messages are deleted, what is being debated: data or intuition? Only those who can read the papers have the answer.